Health Care & Life Sciences » Biotechnology | Stellar Biotechnologies Inc.

Stellar Biotechnologies Inc.

Stellar Biotechnologies Inc.
Stock Exchange NASDAQ Stock Market
EPS
$3
Market Cap
$7.46 M
Shares Outstanding
5.33 M
Public Float
4.53 M

Profile

Address
332 East Scott Street
Port Hueneme California 93041
United States
Employees -
Website http://www.stellarbiotechnologies.com
Updated 09/14/2018
Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded on June 12, 2007 and is headquartered in Port Hueneme, CA.

Financials

View All
Created with Highcharts 5.0.14Stellar Biotechnologies Inc.Net Income. Fiscal year is October-September. All values USD Thousands.14 88614 8867 8337 8332 8432 8435 0265 0265 0305 0302013201420152016201702.5k5k7.5k10k12.5k15k17.5k
Created with Highcharts 5.0.14Stellar Biotechnologies Inc.Sales/Revenue. Fiscal year is October-September. All values USD Thousands.5455453453457587581 2711 271228228201320142015201620170250500750100012501500

Tessie Mary Che
Director
Deborah F. Aghib
Independent Director